Front Row lecture series

How microbes are rewriting the rules of immunity

Howard Hang, PhD
Chair and Professor, Department of Immunology & Microbiology
Wednesday, October 8, 2025
4:00 p.m. PT | 7:00 p.m. ET

How do microbes influence our immune system, and can we leverage this relationship to combat disease? In this free Front Row lecture, Scripps Research Professor Howard Hang delved into his lab’s innovative work at the intersection of chemistry, microbiology and immunology. By dissecting the molecular dialogues between gut bacteria and human cells, Hang’s research uncovers how microbial enzymes generate small molecules—called microbial metabolites—that can influence immune responses. These insights are paving the way for new treatments against infections, cancer and inflammatory illnesses, highlighting the powerful role that microbes play in shaping human health.

Presented: October 8, 2025

Presentation slides
Key takeaways

Howard Hang, PhD

How do microbes influence our immune system, and can we leverage this relationship to combat disease? In this free Front Row lecture, Scripps Research Professor Howard Hang delved into his lab’s innovative work at the intersection of chemistry, microbiology and immunology. By dissecting the molecular dialogues between gut bacteria and human cells, Hang’s research uncovers how microbial enzymes generate small molecules—called microbial metabolites—that can influence immune responses. These insights are paving the way for new treatments against infections, cancer and inflammatory illnesses, highlighting the powerful role that microbes play in shaping human health.

Speaker Spotlight

20240129 Helmsley 920x500


Scripps Research and Calibr-Skaggs awarded $4.5M from the Helmsley Charitable Trust

Michael Bollong, Howard Hang and additional researchers will lead projects to uncover new therapeutic options for Crohn’s disease, one of the most common forms of IBD.


Learn More

Maxresdefault


Species of gut bacteria boosts response to cancer immunotherapy—and now we know why

Using the bacteria to ‘remodel’ a patient’s gut microbiota may improve efficacy of checkpoint inhibitors.


Learn More

1920x1080 It Takes Guts 960x540


It takes guts

With divergent thinking that spans the disciplines of chemistry, microbiology, immunology and oncology, Howard Hang is discovering how microorganisms may be formidable allies in the treatment of infections, cancer and other major diseases.


Learn More